Biomerica, Inc. (BMRA)
2.142
-0.09
(-4.17%)
USD |
NASDAQ |
Oct 02, 16:00
2.15
+0.01
(+0.37%)
After-Hours: 20:00
Biomerica Shareholders Equity (Quarterly) : 2.63M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 2.63M |
| February 28, 2026 | 3.317M |
| November 30, 2025 | 4.435M |
| August 31, 2025 | 5.155M |
| May 31, 2025 | 4.105M |
| February 28, 2025 | 5.534M |
| November 30, 2024 | 5.114M |
| August 31, 2024 | 5.346M |
| May 31, 2024 | 6.591M |
| February 29, 2024 | 7.808M |
| November 30, 2023 | 9.383M |
| August 31, 2023 | 10.77M |
| May 31, 2023 | 11.72M |
| February 28, 2023 | 5.986M |
| November 30, 2022 | 7.243M |
| August 31, 2022 | 8.322M |
| May 31, 2022 | 8.325M |
| February 28, 2022 | 9.758M |
| November 30, 2021 | 8.901M |
| August 31, 2021 | 8.803M |
| May 31, 2021 | 9.227M |
| February 28, 2021 | 10.60M |
| November 30, 2020 | 11.15M |
| August 31, 2020 | 12.58M |
| May 31, 2020 | 14.21M |
| Date | Value |
|---|---|
| February 29, 2020 | 5.837M |
| November 30, 2019 | 3.376M |
| August 31, 2019 | 3.624M |
| May 31, 2019 | 3.981M |
| February 28, 2019 | 3.961M |
| November 30, 2018 | 4.412M |
| August 31, 2018 | 4.078M |
| May 31, 2018 | 4.335M |
| February 28, 2018 | 4.032M |
| November 30, 2017 | 4.027M |
| August 31, 2017 | 4.287M |
| May 31, 2017 | 4.489M |
| February 28, 2017 | 4.820M |
| November 30, 2016 | 5.019M |
| August 31, 2016 | 5.165M |
| May 31, 2016 | 5.220M |
| February 29, 2016 | 5.389M |
| November 30, 2015 | 5.473M |
| August 31, 2015 | 5.536M |
| May 31, 2015 | 5.600M |
| February 28, 2015 | 5.348M |
| November 30, 2014 | 5.461M |
| August 31, 2014 | 5.698M |
| May 31, 2014 | 5.914M |
| February 28, 2014 | 5.728M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Univec, Inc. | -18.31M |
| Lantheus Holdings, Inc. | 1.312B |
| Zomedica Corp. | 107.28M |
| IDEXX Laboratories, Inc. | 1.613B |
| Neogen Corp. | 2.093B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.759M |
| Total Liabilities (Quarterly) | 4.129M |
| Debt to Equity Ratio | 0.9061 |
| Current Ratio | 1.619 |
| Net Debt Paydown Yield | -4.82% |